Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

A challenging mitral valve anatomy for percutaneous repair with MitraClip: cleft posterior leaflet.

Melillo E, Ancona F, Buzzatti N, Denti P, Agricola E.

Eur Heart J Cardiovasc Imaging. 2019 Jun 25. pii: jez175. doi: 10.1093/ehjci/jez175. [Epub ahead of print] No abstract available.

PMID:
31577347
2.

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.

Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, Lurz P, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Loureiro R, Fam N, Frerker C, Gavazzoni M, Hausleiter JR, Ho E, Juliard JM, Kaple R, Besler C, Kodali S, Kreidel F, Kuck KH, Latib A, Lauten A, Monivas V, Mehr M, Muntané-Carol G, Nazif T, Nickening G, Pedrazzini G, Philippon F, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Scha Fer U, Schofer J, Sievert H, Tang GHL, Thiele H, Topilsky Y, Rommel KP, Delgado V, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Leon MB, Hahn RT, Bax JJ, Enriquez-Sarano M, Maisano F.

J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37739-3. doi: 10.1016/j.jacc.2019.09.028. [Epub ahead of print]

PMID:
31568868
3.

Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction.

Melillo F, Ancona F, Calvo F, Fisicaro A, Stella S, Capogrosso C, Spoladore R, Denti P, Melisurgo G, Lapenna E, Pappalardo F, Castiglioni A, Margonato A, Agricola E.

J Invasive Cardiol. 2019 Sep;31(9):E274-E276.

4.

1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.

Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, Weber M, Yzeiraj E, Schiavi D, Mangieri A, Vaskelyte L, Alessandrini H, Deuschl F, Brugger N, Ahmad H, Biasco L, Orban M, Deseive S, Braun D, Rommel KP, Pozzoli A, Frerker C, Näbauer M, Massberg S, Pedrazzini G, Tang GHL, Windecker S, Schäfer U, Kuck KH, Sievert H, Denti P, Latib A, Schofer J, Nickenig G, Fam N, von Bardeleben S, Lurz P, Maisano F, Hausleiter J.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461. doi: 10.1016/j.jcin.2019.04.019.

PMID:
31395215
5.

Leaflet edge-to-edge treatment versus direct annuloplasty in patients for functional mitral regurgitation.

Weber M, Öztürk C, Taramasso M, Pozzoli A, Pfister R, Wösten M, Alessandrini H, Latib A, Denti P, Kuck KH, Maisano F, Baldus S, Nickenig G.

EuroIntervention. 2019 May 21. pii: EIJ-D-19-00468. doi: 10.4244/EIJ-D-19-00468. [Epub ahead of print]

6.

Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review.

Hahn RT, Waxman AB, Denti P, Delhaas T.

JAMA Cardiol. 2019 May 1;4(5):478-487. doi: 10.1001/jamacardio.2019.0535.

PMID:
30994879
7.

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02174-18. doi: 10.1128/AAC.02174-18. Print 2019 Jun.

PMID:
30910890
8.

Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.

Sorajja P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Popma JJ, Blanke P, Leipsic J, Muller D.

J Am Coll Cardiol. 2019 Mar 26;73(11):1250-1260. doi: 10.1016/j.jacc.2018.12.066.

PMID:
30898200
9.

Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: A propensity-weighted analysis.

Buzzatti N, Van Hemelrijck M, Denti P, Ruggeri S, Schiavi D, Scarfò IS, Reser D, Taramasso M, Weber A, La Canna G, De Bonis M, Maisano F, Alfieri O.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):86-94.e1. doi: 10.1016/j.jtcvs.2019.01.023. Epub 2019 Jan 22.

PMID:
30797588
10.

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.

Naidoo A, Chirehwa M, Ramsuran V, McIlleron H, Naidoo K, Yende-Zuma N, Singh R, Ncgapu S, Adamson J, Govender K, Denti P, Padayatchi N.

Pharmacogenomics. 2019 Mar;20(4):225-240. doi: 10.2217/pgs-2018-0166. Epub 2019 Feb 15.

PMID:
30767706
11.

A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.

Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01964-18. doi: 10.1128/AAC.01964-18. Print 2019 Apr.

12.

Pharmacokinetics, Safety, and Dosing of Novel Pediatric Levofloxacin Dispersible Tablets in Children with Multidrug-Resistant Tuberculosis Exposure.

Garcia-Prats AJ, Purchase SE, Osman M, Draper HR, Schaaf HS, Wiesner L, Denti P, Hesseling AC.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01865-18. doi: 10.1128/AAC.01865-18. Print 2019 Apr.

13.

The Tricuspid Valve Relationship With the Right Ventricle and Pulmonary Vasculature.

Hahn RT, Delhaas T, Denti P, Waxman AB.

JACC Cardiovasc Imaging. 2019 Mar;12(3):564-565. doi: 10.1016/j.jcmg.2018.11.016. Epub 2019 Jan 16. No abstract available.

PMID:
30660539
14.

Chiral optical tweezers for optically active particles in the T-matrix formalism.

Patti F, Saija R, Denti P, Pellegrini G, Biagioni P, Iatì MA, Maragò OM.

Sci Rep. 2019 Jan 10;9(1):29. doi: 10.1038/s41598-018-36434-9.

15.

Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.

Wasserman S, Denti P, Brust JCM, Abdelwahab M, Hlungulu S, Wiesner L, Norman J, Sirgel FA, Warren RM, Esmail A, Dheda K, Gandhi NR, Meintjes G, Maartens G.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02164-18. doi: 10.1128/AAC.02164-18. Print 2019 Mar.

16.

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmeier A, Fam N, Frerker C, Hausleiter J, Himbert D, Ho EC, Juliard JM, Kaple R, Kreidel F, Kuck KH, Ancona M, Lauten A, Lurz P, Mehr M, Nazif T, Nickening G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Sievert K, Tang GHL, Tanner FC, Vahanian A, Webb JG, Windecker S, Yzeiray E, Zuber M, Maisano F, Leon MB, Hahn RT.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.

PMID:
30594510
17.

Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: A single-center experience.

Buzzatti N, Denti P, Scarfò IS, Giambuzzi I, Schiavi D, Ruggeri S, Castiglioni A, De Bonis M, La Canna G, Alfieri O.

Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28029. [Epub ahead of print]

PMID:
30592134
18.

Anesthesiologic Management of Patients Undergoing Cardiac Transapical Procedures: Which Challenges in the Modern Era?

Pieri M, De Luca M, Gerli C, Crivellari M, Buzzatti N, Denti P, Stamelos M, Zangrillo A, Landoni G, Monaco F.

J Cardiothorac Vasc Anesth. 2019 Jul;33(7):1883-1889. doi: 10.1053/j.jvca.2018.10.039. Epub 2018 Oct 28.

PMID:
30581110
19.

Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical study.

Rabie H, Denti P, Lee J, Masango M, Coovadia A, Pillay S, Liberty A, Simon F, McIlleron H, Cotton MF, Lallemant M.

Lancet HIV. 2018 Dec 6. pii: S2352-3018(18)30293-5. doi: 10.1016/S2352-3018(18)30293-5. [Epub ahead of print]

PMID:
30529029
20.

Transcatheter Tricuspid Valve Repair With a Novel Cinching System.

Gheorghe L, Swaans M, Denti P, Rensing B, Van der Heyden J.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):e199-e201. doi: 10.1016/j.jcin.2018.09.019. Epub 2018 Nov 28. No abstract available.

PMID:
30503598
21.

Transcatheter Repair of Severe Functional Tricuspid Insufficiency Using a Mitral Clip System: Transgastric Views Are the Key for an Effective Guide.

Faletra FF, Pedrazzini G, Züber M, Leo LA, Paiocchi V, Maisano F, Denti P, Moccetti T.

JACC Cardiovasc Imaging. 2019 Mar;12(3):554-558. doi: 10.1016/j.jcmg.2018.09.010. Epub 2018 Nov 15. No abstract available.

PMID:
30448138
22.

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.

Daskapan A, Idrus LR, Postma MJ, Wilffert B, Kosterink JGW, Stienstra Y, Touw DJ, Andersen AB, Bekker A, Denti P, Hemanth Kumar AK, Jeremiah K, Kwara A, McIlleron H, Meintjes G, van Oosterhout JJ, Ramachandran G, Rockwood N, Wilkinson RJ, van der Werf TS, Alffenaar JC.

Clin Pharmacokinet. 2019 Jun;58(6):747-766. doi: 10.1007/s40262-018-0716-8. Review.

23.

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Gonzàlez Cabrera D, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01941-18. doi: 10.1128/AAC.01941-18. Print 2018 Nov. No abstract available.

24.

Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement.

Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, Denti P, Latib A, Kiaii B, Bagur R, Ferrari E, Moccetti M, Biasco L, Blanke P, Ben-Gal Y, Banai S.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006412. doi: 10.1161/CIRCINTERVENTIONS.118.006412.

PMID:
30354628
25.

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries.

Pillai G, Chibale K, Constable EC, Keller AN, Gutierrez MM, Mirza F, Sengstag C, Masimirembwa C, Denti P, Maartens G, Ramsay M, Ogutu B, Makonnen E, Gordon R, Ferreira CG, Goldbaum FA, Degrave WMS, Spector J, Tadmor B, Kaiser HJ.

BMC Med Educ. 2018 Oct 10;18(1):233. doi: 10.1186/s12909-018-1331-y.

26.

Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid.

Chirehwa MT, McIlleron H, Wiesner L, Affolabi D, Bah-Sow O, Merle C, Denti P; RAFA team.

J Antimicrob Chemother. 2019 Jan 1;74(1):139-148. doi: 10.1093/jac/dky378.

27.

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing.

Innes S, van der Laan L, Anderson PL, Cotton M, Denti P.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00761-18. doi: 10.1128/AAC.00761-18. Print 2018 Nov.

28.

MitraClip for radiotherapy-related mitral valve regurgitation.

Scarfò I, Denti P, Citro R, Buzzatti N, Alfieri O, La Canna G.

Hellenic J Cardiol. 2018 Jul 26. pii: S1109-9666(18)30237-9. doi: 10.1016/j.hjc.2018.07.006. [Epub ahead of print]

29.

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing.

Ali AM, Penny MA, Smith TA, Workman L, Sasi P, Adjei GO, Aweeka F, Kiechel JR, Jullien V, Rijken MJ, McGready R, Mwesigwa J, Kristensen K, Stepniewska K, Tarning J, Barnes KI, Denti P; WWARN Amodiaquine PK Study Group.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e02193-17. doi: 10.1128/AAC.02193-17. Print 2018 Oct.

30.

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00012-18. doi: 10.1128/AAC.00012-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Oct 24;62(11):.

31.

Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Tanner L, Denti P, Wiesner L, Warner DF.

IUBMB Life. 2018 Sep;70(9):926-937. doi: 10.1002/iub.1866. Epub 2018 Jun 22. Review.

32.

Tricuspid valve imaging.

Ancona F, Stella S, Capogrosso C, Marini C, Fisicaro A, Margonato A, Denti P, Agricola E.

Minerva Cardioangiol. 2018 Dec;66(6):680-690. doi: 10.23736/S0026-4725.18.04698-4. Epub 2018 Apr 11. Review.

PMID:
29642695
33.

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.

Schalkwijk S, Ter Heine R, Colbers AC, Huitema ADR, Denti P, Dooley KE, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Mirochnick M, Burger DM.

Clin Pharmacokinet. 2018 Nov;57(11):1421-1433. doi: 10.1007/s40262-018-0642-9.

34.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

35.

Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.

de Kock M, Tarning J, Workman L, Allen EN, Tekete MM, Djimde AA, Bell DJ, Ward SA, Barnes KI, Denti P.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e01370-17. doi: 10.1128/AAC.01370-17. Print 2018 May.

36.

Optimising mitral repair in functional regurgitation: transcatheter annuloplasty can counteract left ventricle-mitral ring mismatch.

Buzzatti N, Denti P, Alfieri O, La Canna G.

EuroIntervention. 2018 Sep 20;14(7):762-763. doi: 10.4244/EIJ-D-17-01022. No abstract available.

37.

Mitral valve annuloplasty.

Del Forno B, Castiglioni A, Sala A, Geretto A, Giacomini A, Denti P, De Bonis M, Alfieri O.

Multimed Man Cardiothorac Surg. 2017 Oct 6;2017. doi: 10.1510/mmcts.2017.016.

38.

Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies.

Taramasso M, Pozzoli A, Basso C, Thiene G, Denti P, Kuwata S, Nietlispach F, Alfieri O, Hahn RT, Nickenig G, Schofer J, Leon MB, Reisman M, Maisano F.

EuroIntervention. 2018 Mar 20;13(16):1889-1898. doi: 10.4244/EIJ-D-17-00704.

39.

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.

Naidoo A, Ramsuran V, Chirehwa M, Denti P, McIlleron H, Naidoo K, Yende-Zuma N, Singh R, Ngcapu S, Chaudhry M, Pepper MS, Padayatchi N.

Pharmacogenomics. 2018 Jan;19(1):17-29. doi: 10.2217/pgs-2017-0144. Epub 2017 Dec 6.

40.

Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.

Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, Dooley KE, Savic RM, McIlleron HM, Schaaf HS, Hesseling AC.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01521-17. doi: 10.1128/AAC.01521-17. Print 2018 Feb.

41.

Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.

van der Laan LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, Wiesner L, de Kock M, Winckler J, Norman J, McIlleron H, Denti P, Hesseling AC.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e00420-17. doi: 10.1128/AAC.00420-17. Print 2018 Feb.

42.

Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial.

Gammie JS, Bartus K, Gackowski A, D'Ambra MN, Szymanski P, Bilewska A, Kusmierczyk M, Kapelak B, Rzucidlo-Resil J, Moat N, Duncan A, Yadev R, Livesey S, Diprose P, Gerosa G, D'Onofrio A, Pitterello D, Denti P, La Canna G, De Bonis M, Alfieri O, Hung J, Kolsut P.

J Am Coll Cardiol. 2018 Jan 2;71(1):25-36. doi: 10.1016/j.jacc.2017.10.062. Epub 2017 Nov 1.

43.

Response to "Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy".

de Kock M, Tarning J, Barnes KI, Denti P.

CPT Pharmacometrics Syst Pharmacol. 2017 Nov;6(11):731. doi: 10.1002/psp4.12256. Epub 2017 Oct 20. No abstract available.

44.

Mitral Valve-in-Ring Implantation With a Dedicated Transcatheter Mitral Valve Replacement System.

Cheung A, Denti P, Kiaii B, Bagur R, Webb J, Latib A, Alfieri O.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):2012-2014. doi: 10.1016/j.jcin.2017.08.019. No abstract available.

45.

The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?

Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard JM, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schäfer U, Schofer J, Schueler R, Tang G, Vahanian A, Webb JG, Yzeiraj E, Maisano F, Leon MB.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):1982-1990. doi: 10.1016/j.jcin.2017.08.011.

46.

Systolic anterior motion after mitral valve repair: a predictive computational model.

Denti P, Pozzoli A, Geretto A, Vicentini L, Di Sanzo S, Monaco F, Crivellari M, Buzzatti N, De Bonis M, La Canna G, Redaelli A, Alfieri O.

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):513-519. doi: 10.1093/icvts/ivx186.

PMID:
28962497
47.

The big parade: emerging percutaneous mitral and tricuspid valve devices.

Natarajan D, Joseph J, Denti P, Redwood S, Prendergast B.

EuroIntervention. 2017 Sep 24;13(AA):AA51-AA59. doi: 10.4244/EIJ-D-17-00571. Review.

48.

Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy.

Svensson EM, Yngman G, Denti P, McIlleron H, Kjellsson MC, Karlsson MO.

Clin Pharmacokinet. 2018 May;57(5):591-599. doi: 10.1007/s40262-017-0577-6.

49.

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.

Chirehwa MT, McIlleron H, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, Denti P.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00490-17. doi: 10.1128/AAC.00490-17. Print 2017 Aug.

50.

Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery.

de Kock M, Tarning J, Workman L, Nyunt MM, Adam I, Barnes KI, Denti P.

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):430-438. doi: 10.1002/psp4.12181. Epub 2017 Jun 9.

Supplemental Content

Support Center